Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25F6AFQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,659
Award facts
- Contract value 100% obligated
- $37,659.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 MG/20 ML vials. The contract, awarded on September 9, 2025, with an ultimate completion date of September 30, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the procurement of comprehensive pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. EXPAREL, a bupivacaine liposome injectable suspension, is a long-acting local anesthetic commonly used in surgical and pain management applications within military medical settings. The company's established track record of consistent contract awards and its position as a woman-owned small business have enabled it to compete effectively in federal procurement markets while maintaining robust pharmaceutical distribution capabilities across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DX25F6AFQ?
SPE2DX25F6AFQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 9, 2025.
How much is contract SPE2DX25F6AFQ worth?
The government has obligated $37,659 on SPE2DX25F6AFQ.
Is contract SPE2DX25F6AFQ an order under another contract?
Yes. SPE2DX25F6AFQ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFQ competed?
The extent of competition for SPE2DX25F6AFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award